Coronary ventricular hemodynamic responses reversal flunitrazepam-induced sedation flumazenil patients coronary artery disease effects reversal flunitrazepam-induced sedation flumazenil coronary hemodynamics myocardial oxygen consumption ventricular LV performance double-blind trial patients stable coronary artery disease undergoing cardiac catheterization Coronary sinus blood flow continuous thermodilution Arterial coronary sinus blood oxygen lactate contents determinants LV performance cardiac output thermodilution left heart catheterization data flunitrazepam-induced sedation patients placebo flumazenil increment mg end procedure placebo group significant hemodynamic changes flumazenil group heart rate cardiac index maximum velocity shortening relaxation time constant contrast mean aortic pressure LV end-diastolic pressure baselines mmHg flumazenil administration changes return presedation values coronary resistance whereas CSBF baseline ml/min electrocardiographic evidence myocardial ischemia study data reversal benzodiazepine effects flumazenil major alteration LV systolic function relaxation coronary hemodynamics patients coronary artery disease LV end-diastolic pressure time administration 